If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksImperial Innovations Group Share News (IVO)

  • There is currently no data for IVO

Imperial Innovations Group News

Imperial Innovations' Circassia Prices IPO
13 Mar 2014

Imperial Innovations' Circassia Prices IPO

LONDON (Alliance News) - Imperial Innovations Group PLC Thursday said its largest portfolio company, Circassia Pharmaceuticals, has successfully price...

Imperial Innovations' Circassia to list on LSE main market
6 Feb 2014

Imperial Innovations' Circassia to list on LSE main market

Clinical-stage specialty biopharmaceutical company Circassia has announced its intention to float on the London Stock Exchange's Main Market. The com...

UK MORNING BRIEFING: Vodafone Gains, AstraZeneca Falls At Open
6 Feb 2014

UK MORNING BRIEFING: Vodafone Gains, AstraZeneca Falls At Open

LONDON (Alliance News) - Vodafone has delivered results in line with expectations Thursday morning, helping to give UK share a positive start. Vodafon...

UPDATE 1-Circassia seeks $285 mln in bumper UK biotech IPO
6 Feb 2014

UPDATE 1-Circassia seeks $285 mln in bumper UK biotech IPO

* Allergy firm tests European market for larger biotech IPOs * Follows boom in biotech offerings in United States * Funds to help bring cat allergy va...

UK MORNING BRIEFING:
6 Feb 2014

UK MORNING BRIEFING:

LONDON (Alliance News) - Vodafone has delivered results in line with expectations Thursday morning, helping to give UK share a positive start. Vodafon...

Allergy drug firm Circassia seeks $285 mln in London IPO
6 Feb 2014

Allergy drug firm Circassia seeks $285 mln in London IPO

LONDON, Feb 6 (Reuters) - Circassia, a company developing allergy treatments based on a discovery by scientists at Imperial College in London, plans t...